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Effect of parathyroidectomy on nephrotoxic serum nephritis. A.
C. A/frey, R. C. Tomford, and M. L. Karlinsky. V.A. Medical
Center, Denver, Colorado. Phosphorus restriction (PR) has been
shown to prevent calcification, histologic damage, and progres-
sive functional deterioration in the remnant kidney and nephro-
toxic serum nephritis (NSN) models of renal failure. This study
was performed to determine if this protective effect is mediated
through the suppression of parathyroid hormone (PTH). Eleven
rats were parathyroidectomized (PTX) 10 days prior to and 12
rats were PTX 30 to 70 days after the induction of NSN. An
additional 12 rats received NSN alone and served as controls.
Values are given as mean SD. PTX had no effect on the heterol-
ogous phase proteinuria (P), 254 81 vs. 276 60 mg/day (nor-
mal, < 20 mg/day), but prevented the rise in P during the autolo-
gous phase, 609 160 vs. 298 81 mg/day (P <0.05). PTX also
partially prevented the elevated plasma cholesterol (Ch), 183
38 vs. 134 38 mgldl (P < 0.05) (normal, 35 3 mg/dl), com-
pletely prevented elevated serum triglycerides (TG), 706 314 vs.
154 65 mgldl (P < 0.05) (normal, 135 11 mgldl), and amelio-
rated the decreased serum albumin, 2.4 0.2 vs. 2.7 0.2 mg/dl
(P < 0.05). PTX after the autologous phase is well established and
produced a small decrease in Ch, 234 69 to 181 63mgldl (P <
0.05), a significant improvement in TO, 1185 554 to 181 149
mg/dl (P <0.05), without a change in serum albumin, and a re-
duction in P, 517 196 to 311 112*. Histologic changes were
minimal in the PTX NSN animals, whereas in control NSN ani-
mals there was extensive crescent formation and marked inter-
stitial inflammatory changes with tubular dilatation and drop out.
All animals from each group showed intense linear staining to rat
IgG. Kidney calcium concentration was 14.8 6.9 mmoles/kg in
NSN PTX vs. 619 564 mmoles/kg in NSN controls (P < 0.001).
PTX prior to initiation of NSN over a 24-week period improved
survival (100% vs. 30%) and prevented functional deterioration
(serum creatinine, 0.60 0.17 vs 3.4 1.6 mg/dl). Conclusion.
(I) PR protective effect is mediated through PTH suppression.
(2) PTH has an independent effect on increasing TG in the ne-
phrotic syndrome. (3) The autologous phase proteinuria, func-
tional deterioration, and histologic damage of NSN can be pre-
vented or reduced by PTX.
Iron absorption in chronic renal failure. W. R. Bezwoda, D. P.
Derman, A. P. MacPhail, and T. H. Bothwell. Johannesburg
Hospital, South Africa. Iron absorption in chronic renal failure
treated by means of chronic hemodialysis was studied in 16 pa-
tients by using whole body counting after administration of an
oral dose of 3 mg 59Fe-ferrous ascorbate. Simultaneous ferro-
kinetic studies were performed using 55Fe-ferric citrate. Iron
stores of the patients were assessed by using a radioimmuno-
assay for ferritin developed in this laboratory. Seven patients
were studied further following the administration of a 50 mg dose
of ferrous sulphate, in order to establish the absorptive capacity
of these patients for therapeutic doses of iron. Iron absorption in
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renal failure is related to body iron store as measured by the serum
ferritin level according to a log/log relationship. The relationships
log absorption to log ferritin concentration in renal failure is simi-
lar to that found previously in a group of subjects without renal
failure but with widely varying iron stores. The rate of erythro-
poiesis plays a much less significant part in regulating iron ab-
sorption. Therapeutic doses of iron are also absorbed in amounts
related to the patients' iron needs. It is concluded that iron
absorption in chronic renal failure is appropriate to body iron
stores and that no malabsorptive defect for iron exists. Oral iron
therapy may be expected to benefit iron deficient patients, although
in this group of patients studied iron deficiency was rare.
Effect of propranolol on parathyroid hormone in hemodialysis
patients. G. M. Carney, R. van zyl Smit, M. D. Pascoe, and J.
Coetzee. Renal Unit, Groote Schuur Hospital, South Africa.
Retrospective studies associate propranolol therapy in hemo-
dialysis patients with both reduced renal osteodystrophy and
plasma parathyroid hormone (PTH) level. In this study, 14 cen-
ter hemodialysis patients, not on beta-blockers, were given In-
deral, 40 mg, twice a day. Thirteen other patients on center he-
modialysis were selected as controls. Blood samples were drawn
on the first day, and 14 days after commencement of the trial
serum calcium, phosphate, and alkaline phosphatase were mea-
sured by autoanalyzer methods. PTH was measured by radioim-
munoassay. A fall in PTH level was measured in 12 out of 14
patients on Inderal therapy. A statistically significant reduction
in mean PTH level was found in the test group (P < 0.005) but
not in the control group. There were no statistically significant
changes in calcium, phosphate, and alkaline phosphatase in the
test or control group. We conclude that propranolol reduces
PTH in hemodialysis patients.
Immune function in glomerulonephritis. G. M. Carney, R. S.
Walls, C. R. P. George, J. Payne, R. C. Newland, and J. R.
Lawrence. Renal Unit, Repatriation General Hospital, Concord,
Sydney, Australia. Defective immunity may prevent antigen
elimination and thereby predispose to immune complex forma-
tion and deposition. This mechanism may be important in im-
mune complex glomerulonephritis. Forty-four sequential pa-
tients were studied who satisfied the following criteria: serum
creatinine,  0.2 mmoles/liter; renal biopsy which allowed
unequivocal histologic classification and in which immune depos-
its were demonstrated by immunofluorescence or electron mi-
croscopy; not receiving corticosteroids or immunosuppressives.
We demonstrated in patients with glomerulonephritis, compared
with age-, and sex-matched normal controls: (1) Elevated serum
levels of several immunoglobulin classes in various forms of gb-
merubonephritis—a novel finding was raised 1gM in 4 of 9 pa-
tients with focal sclerosing glomerubonephritis and glomerular
1gM deposition. (2) Patients with all forms of glomerubonephritis
showed significant reduction in antibody response to tetanus tox-
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oid compared with controls in their mean rise in titre (P < 0.05)
and in numbers failing to respond (P < 0.01). (3) No impairment
in T cell function as measured by delayed hypersensitivity skin
tests or DNCB sensitization; however, 8 patients (20%) had a
reduced response to PHA stimulation of whom only 1 (a patient
with tuberculosis) had an inhibitory serum factor. We suggest
these results indicated immunological activity which may be im-
portant in the genesis of glomerulonephritis.
Porphyrins in renal transplantation. R. S. Day and L. Eales.
Porphyria Research Unit, Department of Medicine, University
of Cape Town, at Groote Schuur Hospital, South Africa. Our
previously reported studies of porphyrins in chronic renal failure
clearly indicated that urinary coproporphyrin is of renal and not
hepatic origin. Here we report our results from daily measure-
ments of the urinary porphyrins excreted by 38 renal transplant
cases monitored from the initial day of transplantation until dis-
charge or rejection. The sensitive and informative quantitative
method of fluoroscanning porphyrin methyl esters after separa-
tion by thin layer chromatography was used. In all cases ex-
cellent correlation was observed between urinary coproporphy-
rin levels and creatinine clearance. The results corroborate the
theory that urinary coproporphyrin is synthesized in the kidney
and suggest that these levels might be monitored as a supportive
measure of renal function. The porphyrin status of a patient with
variegate porphyria who received a cadaver transplant in 1971
was reevaluated in the light of this research. The graft was highly
successful and the posttransplant urinary coproporphyrins rose
to levels well above normal. The fact that excess porphyrins
were synthesized in the nonporphyric organ invokes the exis-
tence of an unknown endogenous porphyrinogen in the plasma of
patients with variegate porphyria.
Blood lipids, uric acid, and allopurinol therapy in patients on
maintenance hemodialysis. R. 0. Doehring, A. M. Meyers, and
D. Mendelsohn. Renal Unit, Johannesburg Hospital, University
of Witwatersrand Medical School and South African Inst it utefor
Medical Research. A strong correlation is known to exist be-
tween uric acid and lipid levels in the serum of patients on main-
tenance hemodialysis, in whom both tend to be elevated. The
present study attempts to define whether this relationship is
causal or simply associative, by therapeutically lowering urate
levels by means of allopurinol, a xanthine oxidase inhibitor. Nine
patients, all compliant and stabilized on maintenance hemo-
dialysis for at least 6 months, were included in the study, which
involved the estimation of uric acid, triglyceride, total cholester-
ol, and the high- and low-density lipoprotein fractions before and
after 4 and 10 weeks of treatment on allopurinol (300 mg/day).
Diet, medications, and dialysis methods remained constant
through the study period. Significant correlations were found be-
tween uric acid and both triglyceride (r = 0.34) and cholesterol (r
= 0.47). Serum urate decreased in all 9 patients, from an initial
mean of 0.47 to 0.33 mmoles/liter after 10 weeks' treatment,
whereas lipids dropped in 7 of the 9, triglyceride from a mean of
2.87 to 2.54 mmoles/liter and cholesterol from 5.94 to 5.15
mmoles/liter. The fall in both lipid components just failed to
reach statistical significance on the paired t test and Wilcoxon' s
pair difference test (0.05 <P < 0.1). No consistent change was
found in the high- to low-density lipoprotein ratio. The potential
implications of the findings of this pilot study to the prophylaxis
of atherosclerosis would seem amply to justify its extension to
include a statistically more adequate patient sample, and the in-
vestigation of other urate lowering drugs.
The South African Registry for Dialysis and Transplantation:
First annual report. K. T. Furman and B. R. Briggs. Renal Unit,
Johannesburg Hospital, Johannesburg, South Africa. A South
African National Registry for renal replacement therapy has
been established under the aegis of the National Kidney Founda-
tion, South African Renal Society, the Renal Care Society, and
the Southern African Transplantation Society. A computer pro-
gram specific for the needs of South Africa is being developed
while financial and other requirements are being negotiated. In
the interim, registration has been proceeding through the good
offices and facilities of the E.D.T.A. Registry in London. The
initial registration of patients on treatment in 1978 has been pro-
cessed. Questionnaires were returned from 16 treatment centers
and their satellites with data on a total of 491 patients, of which
304 were on hospital hemodialysis, 34 on home hemodialysis, 39
on maintenance peritoneal dialysis, and 114 who were alive with
functioning grafts. These figures are incomplete in that they are
estimated to represent only about 60% of all South African pa-
tients on treatment. Despite this, valid statistics and information
are now available on the causes of renal failure, technical details
of treatment, water preparation, efficacy in terms of rehabilita-
tion, complications including bone disease, dementia and malig-
nancy, and causes of death on treatment.
Toxicity and efficacy of intraperitoneal iodine. K. I. Furman
and H. Kündig. Department of Experimental and Clinical Phar-
macology, University of the Witwatersrand, Johannesburg,
South Africa. The most serious and frustrating complication that
limits the use of maintenance peritoneal dialysis is the occur-
rence of peritonitis. In most instances, this is due to infection
with skin bacteria especially Staph. epidermidis. One of the pro-
phylactic and therapeutic measures that has been advocated is
the use of routine saline-iodine flushes. The dosages and method
of applying this procedure varies in different centers, and thus far
the results have been equivocal. To assess the toxic potential and
efficacy of i.p. iodine, a series of animal and in vitro studies were
undertaken with povidone-iodine, tincture of iodine, and Lugol's
iodine solutions. It was noted that although there were quan-
titative differences between the various solutions when given as
such, the dose-effect relationships became very similar when the
amounts injected i.p. were adjusted to be equivalent in terms of
available free iodine. In rats, the LD5O of the i.p. administered
iodine solutions ranged equally from 2.50 to 3.00 mI/kg of solu-
tions containing 10,000 ppm available free iodine. With serial di-
lutions, it was possible to demonstrate evidence of chemical peri-
tonitis in rats, mice, and rabbits within 24 hours of an i.p. injec-
tion of 1 mI/kg containing as little as 50 to 100 ppm of free iodine.
With in vitro studies, complete inhibition of Staph. epidermidis
in peptone broth could only be obtained when the iodine concen-
tration exceeded 20 ppm and provided the bacterial count was
less than 1 million/ml. From these studies the therapeutic index
of i.p. iodine solutions appear to be rather low, and the risk of
developing chemical peritonitis with repeated administration of
effective doses remains a distinct possibility which is likely to
preclude long-term prophylactic use.
Microvascular changes in experimental paracetamol nephropa.
thy. K. I. Furman and J. R. Lewin. Dept. of Experimental and
Clinical Pharmacology and Dept. of Pathology, University of
the Witwatersrand, Johannesburg, South Africa. The presence
of abnormal microvessels in the kidney and lower urinary tract is
regarded as being one of the typical pathologic features to be
found in analgesic nephropathy. Similar changes have been ob-
served by us in an experimental model of paracetamol nephropa-
thy in rats, in which the nephrotoxic effects of the analgesic were
enhanced by the simultaneous presence of active E. coli-induced
pyelonephritis. The vasculopathy was noted to be mainly present
in the vessels of the medullary interstitium and the pelvic sub-
mucosal region of rat kidneys that had developed papillary ne-
crosis. The affected vessel walls stained heavily with PAS, sil-
ver and Masson's stains, indicating that the observed thickening
was due to an increase in collagen tissue. These findings under-
line the nephrotoxic potential of paracetamol and indicate that
the experimental nephropathy is analogous to the human disease
associated with analgesic abuse.
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Results of renal transplantation in patients with polycystic dis-
ease of the kidney. P. Graff, A. M. Meyers, F. J. Mime, andJ. R.
Botha. Dept. of Medicine & Surgery, University of the Witwa-
tersrand, Johannesburg, South Africa. Eighteen patients with
polycystic renal disease who received transplants between 1970
and 1977 at Johannesburg Hospital were reviewed, in order that
the patient mortality, morbidity, and actuarial graft survival of
this group might be compared with that of a randomly selected
control transplant population. The control population was
formed by an age-matched group of patients with chronic gb-
merulonephritis, pyelonephritis, and analgesic nephropathy who
received transplants over the same period. The control popu-
lation was further subdivided into two groups: (1) chronic gb-
merulonephritis and (2) pyelonephritis and analgesic nephropa-
thy. The two groups were represented within the control popu-
lation in the ratio of 2:1. No statistically significant differences
existed between the actuarial patient survival rates of poly-
cystics and the age-matched control group. Furthermore, there
were no ascertainable differences in the quality of renal function
in the two groups in the posttransplant period. Morbidity pat-
terns were essentially similar, and in both groups gross sepsis
constituted the principal cause of demise, Graft rejection, how-
ever, was documented with significantly greater frequency in the
control population. On the basis of a review of a limited group of
patients with polycystic disease, it appears that their suitability
as candidates for renal transplant is not significantly different
from that of other age-matched patients with end-stage renal fail-
ure.
Treatment of dialysis fracturing bone disease. G. A. Hudson, F.
J. Mime, A. M. Meyers, P. Reis. Division of Nephrology, De-
partments of Medicine and Radiology, University of the Witwa-
tersrand, Johannesburg, South Africa. A previous study demon-
strated disproportionate radiographic osteomalacia/osteopenia
(OM/OP) in chronic hemodialysis patients dialyzed against soft-
ened water with a high aluminium content. For this study, 15
patients (5M: 1OF) with radiographic OM/OP, who have been on
dialysis for at least 2 years, have been selected in order to assess
prospectively the therapeutic efficacy of pure water, la-vitamin
D3 (in D3) and successful transplantation. Full skeletal X-rays,
serum calcium, phosphorus, alkaline phosphatase, and para-
thyroid hormone levels and a clinical questionnaire was taken
before and again after at least 3 months of the particular treat-
ment. Group A (5 patients; 1M:4F; mean age, 51 years) did not
change their dialysate water. Group B (6 patients; 3M:3F; mean
age, 45) changed to pure water. Group C (6 patients; all F; mean
age, 39) commenced la-D3. Group D (3 patients; iM:2F; mean
age, 35) were transplanted. The mean duration of treatment of
groups B and C was 9.3 and 9.9 months, respectively. The 2
group A patients on deionized water remained the same radio-
logically, but progressive OM/OP occurred in the 3 on softened
water. The change to pure water produced remarkable clinical
and radiologic improvement in 4 of the 6 patients, with reversal
of disease in 2. Oral la-D3 produced symptomatic improvement
in 4 of the 6, and in 2 the radiologic symptoms reversed. All 3
transplanted patients have shown a steady clinical improvement,
but as yet no biochemical or radiologic improvement. Our results
indicate that none of the treatments have improved the biochemi-
cal parameters within the mean 10 months of treatment. Radio-
logic response occurred slowly in the ia-D3 and pure water
groups, but a dramatic clinical improvement was seen in all pa-
tients changing to a pure water supply.
Hypertension in the posttransplant patient. A. Kark, J. Cohen,
J. Milne, A. Meyers, and J. Botha. Departments of Medicine
and Surgery, University of Witwatersrand, Johannesburg, South
Africa. To assess the relationship of postrenal transplant hyper-
tension to steroid dose, urinary tract infection, serum creatinine,
urinary protein excretion, and body weight, we performed the
following study. Methods. All patients transplanted in this unit
with a graft functioning for 5 years or longer were studied retro-
spectively at varying intervals. Hypertension was defined as a
blood pressure of 140/95 or above on more than three occasions.
Steroid dose was taken as the mean dose recommended for the
month prior to the onset of hypertension, or prior to the end of
the time period studied. Urinary tract infection was defined as
the presence of greater than 100,000 colonies on culture of a
single organism, or as assessed as being a significant infection by
the transplant unit. Serum creatinine, urinary protein excretion,
and weight were taken as the mean value in the month prior to
the onset of hypertension, or prior to the end of the time period
studied. Results. Of the 78 patients, 67 developed hypertension
at some stage posttransplantation. The development of hyper-
tension bore no correlation with body weight, occurrence of uri-
nary tract infection, or urinary protein excretion. There was a
significant direct correlation with steroid dose at 6 months, and
with serum creatinine at all intervals from the 2nd to 7th year.
Conclusions. These findings suggest that renal insufficiency is of
importance in the development of hypertension following renal
transplantation. Steroid dose is of importance only at very high
levels. No association was found with age, sex, urinary infec-
tion, body weight, protein excretion, or primary kidney disease.
Nephrectomy did appear to lessen the risk of development of
hypertension but this did not attain statistical significance.
Diagnostic value of urine and serum indices in azotemia. G. R.
Keeton, M. Golden, and H. Daya. Departments of Medicine and
Pathology, Somerset Hospital, South Africa. To predict prerenal
and intrinsic renal failure using random blood and urine indices,
we performed the following study. Methods. Fifty-seven patients
(mean age, 56.1) with elevated serum urea and/or creatinine lev-
els were included. One observer assessed them clinically while 2
others interpreted the random blood and urine electrolytes, urea,
creatinine, and glucose values. Predictive indices were defined
as urine sodium values less than 20 mmoles/liter, Uurea/Purea ra-
tios of less than 10 and 10 to 39, and the P,/Pua ratio less than
12. Sixteen normal controls produced U/Puea ratios of 58 to 107
with a mean of 80.4 after 24 hr of fluid deprivation. Results.
Fourteen patients had urine sodiums of less than 20 mmoles/liter,
all of which were associated with prerenal factors including vol-
ume depletion, hypotension, cardiac failure, intrinsic renal is-
chemia, steroids and one case of hepatorenal failure. Pcr/Pua
ratios of less than 12 were found in 26 patients with hyper-
catabolic states (septicemia, steroids, tetracycline), intrinsic renal
ischemia, or marked wasting. Many patients had more than one of
these definitive factors. Suboptimal U/Purea ratios of 10 to 39 in
33 patients resulted from frusemide administration, septicemia or
partial acute tubular necrosis and diabetic osmotic diuresis or
nephropathy. Seventeen patients with U/PUrea ratios of less than
10 had either received frusemide or were in acute or chronic re-
nal failure. Conclusions. This study showed that the normal kid-
ney should concentrate urea maximally when subjected to pre-
renal factors, that the kidney retains the ability to conserve so-
dium even when it can no longer concentrate urea, that the U/
Purea ratio is a sensitive index of early tubular dysfunction, and
that pure dehydration without other factors affecting tubular
function is rare in patients admitted to medical wards. Despite
multiple operative factors, an accurate assessment can be made
using the above biochemical indices and the clinical state of the
patient.
Delayed appearance of true porphyria cutanea tarda in a long-
term hemodialysis patient.]. King, F. J. Mime, D. Vilfoen, W. R.
Bezwoda, R. S. Day, S. Kramer. The Departments of Medicine,
Universities of Witwatersrand and Cape Town, South Africa.
Cutaneous blistering eruptions in hemodialysis patients (RHD)
resembling porphyria cutanea tarda (PCT) have been associated
with normal porphyrin profiles, but recently there have been a
few cases with elevated uroporphyrin levels. The skin lesions
usually develop within one year of dialysis, but we now report a
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case manifesting 7 years after commencing hemodialysis. Por-
phyrins in stool, blood and dialysate were quantitated by fluoro-
scanning after separation using thin-layer chromatography. Red
blood cell and plasma porphyrins were measured by modification
of the method of Schwartz et al. Iron kinetic studies were per-
formed. The patient is a 37-year-old anephric male who started
hemodialysis in 1971. In 1978, he developed increased skin fragil-
ity with blistering of both hands, arms and face, without neuro-
logic or abdominal symptomatology. The skin biopsy was typical
of PCT. He has consumed large quantities of alcohol for many
years. He is HBsAb-positive but with no evidence of chronic
liver disease. His Aldomet and oral iron were stopped, and there
has been progressive improvement of the skin lesions. At the
onset of the disease, markedly elevated plasma uroporphyrins
and 7-carboxyporphyrins and elevated stool isocoproporphyrins
were identified. Dialysate concentration was porphyrin-free even
after chloroquin. Iron studies at the time of the acute attack
showed normal absorption, ferritin levels, and plasma iron turn-
over, and 9 months after stopping oral iron, these values are only
mildly reduced. Mildly elevated uroporphyrins are always found
in RHD, possibly due to failure of normal renal excretion and
failure to pass the dialysis membrane. Therefore, in sporadic or
genetic PCT, decreased hepatic urodecarboxylase activity may
cause greater accumulation of uroporphyrins, predisposing to
skin blistering.
Alcohol-stimulated calcitonin levels in the diagnosis of uremic
hyperparathyroidism. A. M. Meyers, L. Laidley, F. J. Mime, and
J. Levin. Nephrology Division, Department of Medicine and Nu-
clear Physics, Johannesburg Hospital, Johannesburg, South Af-
rica. There still exists great difficulty in determining when a pa-
tient on MHD' has clinical or effective" hyperparathyroidism
(EH) until the disease is far advanced. Most laboratories esti-
mate "native" PTH levels, which are almost invariably raised in
these patients. Likewise, raised ionized calcium levels, while
showing a reasonably close correlation with EH, are affected by
various treatment regimens, dialysate calcium, etc. Twenty pa-
tients on MHD, 12 on MPD2 and 30 controls were studied; data
is available for analysis in 16 of the patients on MHD. After an
overnight fast, 50 to 75 ml of whisky was given orally diluted
with water and blood samples drawn at 0, 5, 15, 30, 60 and 120
mm. Measurements made at time 0 included PTH, calcitonin,
Ca, Pi, and ionized Ca. Serial calcitonins were measured
thereafter. The calcitonin results were divided into two groups.
Group I. There was no statistical difference between controls
and the groups. These patients had the lowest levels of PTH,
normal ionized calciums, no bone X-ray changes, and 4 had un-
dergone previous parathyroidectomies. Group 2. Mean basal lev-
el of control was 0.26 ng/ml; in patients (N = 9), it was 0.74 ng/
ml. Maximum stimulation controls at 15 mm was 0.6 ng/ml; of
patients at 90 mins, it was 2.5 ng/ml. Of two patients with normal
bone X-rays in this group, one subsequently developed florid hy-
perparathyroidism, and one developed posttransplant hyper-
calcemia. Subsequent parathyroidectomy in these 2 and 4 oth-
ers resulted in marked improvement. The PTH levels were di-
vided into three groups. Group 1 12 MIU/ml; Group 2 = 12 to
19 MIU/mI, and Group 3  20 MIU/ml. Of the 6 patients with
proven hyperparathyroidism, 4 fell into Group 3, 1 into Group 2
and 1 into Group 1. This was the patient with normal bone X-
rays, no clinical bone symptoms, and the 'most positive' C2H5-
induced response who had his parathyroidectomy posttrans-
plant. Thus, it is concluded that a positive alcohol-induced cal-
citonin response is an excellent method of uncovering EH and
should be added to the armamenterium of radiologic, biochemi-
cal, and PTH methods of diagnosis. Finally, it is postulated that
"C" cell hyperplasia is responsible for this phenomenon and that
the hyperplasia is consequent upon continuously elevated levels
of ionized calcium.
1MHD is maintenance hemodialysis.
2MPD is maintenance pentoneal dialysis.
Parathyroid hormone and acid/base homeostasis: Evidence
against this hypothesis. A. M. Meyers, F. J. Mime, L. Laidley.
Renal Division, Department of Medicine, Johannesburg Hospi-
tal, Johannesburg, South Africa. In 1970 Willis and later Bazel
postulated that PTH played a fundamental role in acid/base
homeostasis. Muldowney et al suggested that hyper-
parathyroidism resulted in gross renal bicarbonate wasting and
systemic acidosis. These workers subsequently ascribed an im-
portant role to PTH in the genesis of acidosis in patients with
chronic renal failure. In addition, hyperchioremia has been found
in some patients particularly those with gross disturbances of the
Pi:Cl ratio. In order to test these hypotheses we studied 11 pa-
tients with primary hyperparathyroidism. Seven had adenomas
and two hyperplasia at surgery. After an overnight fast the fol-
lowing parameters were measured: total calcium and phos-
phorus, ionized calcium using an Orion SS220 calcium ionalizer
and serum creatinine and chloride levels. After baseline arterial
pH and Paco2 measurements, the patients were given a standard
dose of NH4CI, and the short test of Wrong and Davis was per-
formed. Nine of the eleven patients had creatinine clearances of
90 mllmin/1 .73 m2. In the other two the clearances were 25 and 30
mlIminIl.73 m2. These two patients had mild baseline com-
pensated metabolic acidosis (pH, 7.43; Pco2 28; BE-7). Urinary
pH fell to <5.3 in nine patients while NH4, TA, and total acid
excretion rates were normal in these same nine patients (mean of
52, 42 and 97 jsEq/min, respectively). Bicarbonate infusions
were not performed, as no evidence of baseline acidosis or bicar-
bonaturia was found in these nine subjects. The other two pa-
tients with abnormal acid loads were those with diminished renal
function. Both had bicarbonaturia, and the TmHCO3 performed
in one was reduced (2.2 mEq/dl GFR). Two patients who were
constantly normocalcemic had raised ionized calcium levels. The
nine patients with normal renal function had normal serum chlo-
ride calcium levels. The nine patients with normal renal function
had normal serum chloride levels whereas the two with clear-
ances of 25 and 30 mllmin had chloride levels of 117 and 109
mEq/liter, respectively. It is concluded that P1'H exerts no influ-
ence on bicarbonate reabsorption or NH4 or TA excretion and
the hyperchloremic acidotic status described by others were
found only in patients with an overall decrease in renal function.
Treatment of chronic renal failure with continuous ambulatory
peritoneal dialysis. S. Naicker, R. Rawat, Y. K. Seedat, and C.
Smith. Renal Unit, Addington Hospital, and Department of
Medicine, University of Natal, Durban, South Africa. Continu-
ous ambulatory peritoneal dialysis (CAPD) was introduced in
May 1979 as an alternative to hemodialysis in patients who were
unsuitable for renal transplantation. The aim was to provide ef-
fective dialysis with reduced financial costs. Seven Caucasian
and 2 Coloured patients suffering from chronic renal failure
(CRF) were chosen for CAPD. A Tenckoff catheter was in-
troduced into the peritoneal cavity, and an average of 22 2-litre
Dianeal exchanges were done weekly. A saline-iodine flush was
introduced into the peritoneal cavity in the last exchange at
night. In this study, CAPI) produced a good control of the blood
pressure, blood urea, hemoglobin, and a sense of well being. The
main complication was peritonitis, and it appeared that a saline
iodine flush decreased the incidence of peritonitis. Two patients
died from peritonitis. The cost effectiveness of CAPD compared
with hemodialysis makes CAPD a useful alternative procedure to
hemodialysis provided stringent criteria in the selection of pa-
tients are used.
Bicarbonate dialysis using a sorbent cartridge regeneration sys-
tem (Redy). M. D. Pascoe. Renal Unit, Groote Schuur Hospital,
South Africa. The sorbent dialysis system (Redy) provides a
simple, convenient and mobile system for bicarbonate dialysis in
acute or chronic renal failure. This dialysis system was evaluated
for bicarbonate dialysis. A bicarbonate dialysate was prepared
and the standard Ca, Mg., and K acetate infusate was replaced
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with chloride salts. Five patients were dialyzed on three occa-
sions, each on acetate and bicarbonate dialysate, and plasmaand
bath Na, and plasma pH, HCO3, Po1, Pco3 were evaluated. The
same make of flat plate dialyzer was used for each dialysis. There
was no significant difference for Po2 and Pco2 for the two meth-
ods. Bath Na was significantly less, for bicarbonate dialysate Na
was 98 3.81 (means SD). Acetate dialysate was 118.27 11.2
(P < 0.002). No significant difference was noted at end of dial-
ysis, and no difference either at beginning or end in plasma Na.
Predialysis plasma pH (7.38 0.06 for acetate and 7.38 003
for bicarbonate) were not significantly different. Postdialysis pH
was 7.41 0.04 (acetate) and 7.47 0.08 (bicarbonate) and was
significantly different (P <0.01). Similarly, for plasma bicarbonate
the predialysis results were not significantly different, but highly
statistically significant results were obtained postdialysis (P C
0.001). Conclusion. A simple method for bicarbonate dialysis
was evaluated and shown to be effective in producing higher
postdialysis pH and plasma bicarbonate.
Nephrotic syndrome during Captopril therapy. C. Rosendorff
F. J. Milm, H. Levy, D. T. Ninnin, and J. R. Lewin. Hyper-
tension Clinic and the Department of Pathology, University of
the Wirwatersrand, Johannesburg, South Africa. A 72-year-old
woman was admitted to a clinical trial of Captopril, the orally
active inhibitor of the angiotensin converting enzyme. She has
essential hypertension, and there was no evidence of underlying
renal disease or other systemic disorder. There was a good blood
pressure response to the combination of Captopril (450mg daily)
and hydrochlorothiazide (100 mg daily). From week 26 she de-
veloped gradually increasing proteinuria, hypoalbuminemia, and
hypercholesterolemia. On admission to hospital, during week 54,
she was normotensive but edematous. Her creatinine clearance
was 64 mI/mm, and her urinary protein excretion was 6.5 g/day.
Numerous investigations for a secondary cause of the nephrotic
syndrome were negative. A needle biopsy of the kidney was es-
sentially normal on light microscopy, but on electron microscopy
there was irregular thickening of the basement membrane due to
subepithelial electron-dense deposits. Immunofluorescence
showed + to 2+ deposition of lgG and C3 along the glomerular
capillary ioops. Thus, the features were those of an early mem-
branous glomerulonephritis. The Captopril was stopped, and her
blood pressure and edema controlled on hydrochlorothiazide.
Twelve weeks later, her edema has decreased, her urinary pro-
tein excretion is 1.4 g/day, her serum creatinine is again normal,
and the hypoalbuminaemia and hypercholesterolaemia are re-
turning towards normal. This Captopril-induced membranous
glomerulonephritis is similar to that induced by penicillamine,
and it is of interest that both drugs have sulphydryl groups in
their chemical formulae. It is unlikely to be a coincidence that
compounds which have free sulphydryl groups, and metals such
as mercury and gold, which have a high affinity for sulphydryl
groups, all cause membranous glomerulonephritis. It may be that
it is the sulphydryl chelate which initiates immune complex for-
mation and then nephropathy.
Hemofiltration: ClinIcal and technical aspects of this new meth-
od for the treatment of chronic renal Insufficiency. B. Scheune-
mann, Z. Faith,, and E. Quellhorst. Nephrological Center Nie-
dersacksen, Am Vogelsang, Hann, Meunden, West Germany. In
contrast to hemodialysis (MD), the removal of uremic substances
in hemofiltration (HF) is achieved by means of a convective
transport across membranes of high porosity. Since 1974 more
than 30 patients have been treated by a regular HF program,
three times weekly. Criteria for acceptance were: severe hyper-
tension, hypotension in spite of fluid overload, severe cardiovas-
cular insufficiency, hyperphosphatemia, and severe hyper-
triglyceridemia. In 1978 a cross-over study supported by NIH
was started in order to compare RD with HF treatment in terms
of patients' benefits and costs. Two groups, of' IS random chron-
ic renal insufficiency (CR1) patients each, were treated according
to an A-B-A and a B-A-B sequence (A 5 months 1-ID, B = 5
months HF). Although most biochemical parameters did not
show significant differences, the following characteristic obser-
vations could be made: BUN and serum creatinine increased
slightly during HF, but clinical symptoms of uremia were not
present. FTH levels decreased during HF. Headache, muscle
cramps, and nausea/vomiting occurred less often in HF than in
HD. Hypertension is controlled effectively by HF, the stability
of the circulatory system being better than with HD. In spite of
large amounts of body fluid being removed in HF, posttreatment
blood pressure was higher in HF than in HD. Because of the
lower frequency of collapse reactions, HF should be preferred to
RD in patients with cardiovascular or cerebrovascular disease.
As a result of our investigations, we can conclude that HF is
similar to HD as a regular method of treatment for CR1, but is
more suitable in high-risk patients and possibly also in patients
with bone disease. Furthermore, HF is more suitable for mini-
aturization and is the first step towards a real artificial organ."
Fader vm procoaguiant actIvity in Blacks suffering from com-
mon renal disease. M. A. Seedat, H. W. B. Greig, K K. Seedat,
and S. Christensen. Renal Unit, Department of Medicine and
Department of Haematology, King Edward VIII Hospital and
University of Natal, Durban, South Africa. Plasma factor VIII
activity and platelets were studied to determine whether they re-
sult in a prothrombotic state in common renal diseases and their
clinical significance. Out of 43 Black patients suffering from post-
streptococcal glomerulonephritis, 32 had elevation in factor VIII
levels. Clinical improvement correlated with a decrease in factor
VIII levels. Out of 30 Black patients suffering from nephrotic
syndrome, 28 had elevation in factor VIII level. All except one
with amyloid disease showed proliferative glomerulonephritis on
renal biopsy. Factor VIII decreased in the nephrotic patients
with clinical remission. Of the 23 Black patients suffering from
chronic renal failure, 18 had elevation of the plasma VIII factor,
and this elevation usually persisted. There was no correlation
between factor VIII levels and blood urea, serum complement,
bleeding time, clotting, platelet counts, and fibrin degradation
products. These observations indicate that factor VIII may re-
flect the extent of vascular injury and thus may be useful in the
management of common renal diseases.
Pntterns of renal function in tetanus. M. A. Seedat, M. A. K.
Omar, and Y. K. Seedat. Renal and Respiratory Unit, Depart-
ment of Medicine, King Edward VIII Hospital, and University of
Natal, Durban, South Africa. Retrospective analysis of 104 teta-
nus patients, excluding neonates, admitted to a respiratory unit
over a period of 3 years was done to determine renal function
and possible etiologic factors. Patients were divided into three
groups. Group I had normal blood urea levels on admission and
during illness. Group II had normal blood urea levels on admis-
sion and rising during course of illness. Group HI had elevated
blood urea levels on admission. All patients were monitored for
fluid balance, blood and urine chemistries, central venous pres-
sures, pulse rates, blood pressures, blood and urine cultures.
Criteria suggesting sympathetic overactivity often observed in
severe tetanus included labile blood pressure, marked tachy-
cardia, increased sweating, and cold extremities. Evidence of
sympathetic overactivity in the three groups showed the follow-
ing: (a) 13 out of 67 patients (19%) in group I had sympathetic
overactivity, and 9 died (13%)- (b) 21 of the 27 patients (78%) in
group II had sympathetic overactivity, and 16 died (59%). (c) 7
patients (63%) in group III had sympathetic overactivity and 6
died (55%). Differences in sympathetic overactivity between the
three groups were: Groups I vs. II, P C 0.001; II vs. III, P >
0.05; 1 vs. III, P C 0.01. Differences in death rate between the
groups were: Groups I vs. II, P <0.001:11 vs II1,P >0.005; 1
vs. III, P< 0.01. There was no evidence of established hyper-
tension in all three groups. In group II, 4 patients were observed
to have hypotension prior to death; in 2 patients a rise in blood
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urea preceded the hypotension, whereas the other 2 had hypo-
tension initially, the blood urea rising later. Three patients in
group II had a prerenal rise in blood urea, and this was corrected
with adequate hydration. In all three groups, septicemia and
nephrotoxic antibiotics appeared not to be etiologic factors. Of
the 6 patients, 3 showed acute tubular necrosis on postmortem
examination. We feel that the impairment of renal function was
invariably associated with sympathetic overactivity and carried a
high mortality.
Nephrotoxicity of myeloma light chains. J. F. Falconer Smith,
B. D. Ross, and J. G. G. Ledingham. Nuffield Department of
Clinical Medicine and Clinical Biochemistry, University of Ox-
fbrd, United Kingdom. Despite suggestions that myeloma light
chains (1-c) are "nephrotoxic," no good reasons have been found
to explain why some 1-c's cause renal damage, whereas others do
not. This problem has been approached using isolated perfused
rat kidney. L-c's purified from urine of myeloma patients have
been perfused in various concentrations and under various con-
ditions of pH, perfusion pressure, and GFR in the presence or
absence of agents which affect tubular transport. All 1-c's were
freely filtered and avidly reabsorbed with no demonstrable Tm,
but each was shown to have a characteristic rate of fractional
reabsorption varying between 56% and 86%. L-c's identified im-
munochemically in proximal tubular cells of kidney perfused
normally were absent in the tubules of the nonfiltering metaboli-
cally viable kidney, suggesting tubular uptake largely via luminal,
not peritubular membranes. dyne et al have found that nephro-
toxicity of 1-c's in the rat may depend on the relationship between
the isoelectric point (Pi) of the 1-c and the urine pH. In the pres-
ent study, tubular reabsorption of individual chains has been var-
ied between 20% and 75% of filtered load by alteration of urine
pH between 5.3 and 7.6. These striking differences are likely to
relate to changes in charge carried by I-c, induced by pH changes
and depending on the Pi of the 1-c concerned. A method is now
available therefore for altering tubular handling of filtered 1-c.
Nephrotoxicity may depend on cast formation (? when N and pH
are similar) or may relate to cellular reabsorption (?least when N
and pH are similar). dyne et at show least uremia when pH and
Pi are similar, suggesting the latter mechanism, which is support-
ed by I-c inhibition of membrane Na/K ATPase. These observa-
tions may explain variability of renal prognosis in I-c proteinuria.
Regulation of the urine pH in relation to the N of the excreted
light-chain may become a therapeutic approach to myeloma kid-
ney.
Assessment of left ventricular function in chronic hemodialysis
patients. L. Stein go, J. Milne, P. Lowry, and D. Britten. Divi-
sions of Cardiology and Nephrology, University of the Witwa-
tersrand, Johannesburg, South Africa. There is some evidence
that a pathologic cardiomyopathy develops in patients who have
been on hemodialysis for more than 3 years. We have studied left
ventricular (LV) function in nine patients on chronic hemo-
dialysis to try and demonstrate a functional abnormality. There
were five females and four males, ages ranging from 23 to 50
years. They had been on dialysis for periods ranging from 26 to
108 months. The patients were all anemic with a mean hemoglo-
bin of 7.8 g/dl. At the time of the study all the patients were
normotensive, and three patients were on antihypertensive drugs
including beta blockers. Three of the patients were clinically
overloaded. Each patient had a full clinical, biochemical, and ra-
diologic examination, and underwent echocardiography, simul-
taneous electrocardiography, phonocardiography, and carotid
pulse tracing. From this data, systolic time interval (STI) mea-
surements and echocardiographic assessment of LV function
and structure were made. Eight of the nine patients had unequiv-
ocal LV dilatation without hypertrophy. However, echo-
cardiography demonstrated functional abnormality in only one
patient who was grossly overloaded. LV dilatation correlated
best with clinical overload, time of study postdialysis, cardiotho-
racic ratio with or without pulmonary venous hypertension and
STI measurements. It should be noted that STI measurements
must be interpreted carefully in patients who have abnormal
loading conditions and does not necessarily indicate an alteration
in myocardial contractility. We could only demonstrate an overt
cardiomyopathy in one of our patients who was grossly over-
loaded. The cause for the LV dilatation is unclear, probably mu!-
tifactorial, including anemia, hypertension, and chronic circula-
tory overload.
